Attitudes toward postmenopausal long-term hormone therapy

Qualitative Health Research

Volumn 19, Issue 2, 2009, Pages 207-215

  Kolip, Petra ^a   Hoefling Engels, Nicole ^a   Schmacke, Norbert ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Communication; Doctor patient; Hormone replacement therapy; Menopause; Midlife

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CLINICAL ARTICLE; FEMALE; GERMANY; HEALTH BELIEF; HORMONAL THERAPY; HUMAN; INTERVIEW; LONG TERM CARE; MENOPAUSAL SYNDROME; PATIENT COUNSELING; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITATIVE RESEARCH;

AGED; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; QUALITATIVE RESEARCH;

EID: 58649114320     PISSN: 10497323     EISSN: 15527557     Source Type: Journal    
DOI: 10.1177/1049732308328053     Document Type: Article

References (22)

1. Banister, E.M. (1999). Women's midlife experience of their changing bodies. Qualitative Health Research, 9, 520-537.
2. Bucksch, J., Kolip, P., & Deitermann, B. (2004). Reporting on post-menopausal hormone therapy: An analysis of gynaecologists' Web pages. Medical Informatics and the Internet in Medicine, 29, 211-220.
3. Coney, S. (1994). The menopause industry. How the medical establishment exploits women. Alameda, CA: Hunter House.
4. Du, Y., Dören, M., Melchert, H.U., Scheidt-Nave, C., & Knopf, H. (2007). Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. BMC Womens Health, 7, 19. doi:10.1186/ 1472-6874-7-19
5. European Medicines Agency. (2003). EMEA public statement on recent publications regarding hormone replacement therapy. Retrieved January 18, 2008, from http://www.emea.europa.eu/pdfs/human/press/pus/ 3306503en.pdf
6. Food and Drug Administration. (2008). Questions and answers for estrogen and estrogen with progestin therapies for postmenopausal women (updated). Retrieved January 18, 2008, from http://www.fda.gov/cder/drug/ infopage/estrogens_progestins/Q&A.htm
7. French, L.M., Smith, M.A., Holtrop, J.S., & Holmes-Rovner, M. (2006). Hormone therapy after the Women's Health Initiative: A qualitative study. BMC Family Practice, 7, 61. Retrieved January 18, 2008, from http://www.biomedcentral.com/1471-2296/7/61
8. Glaser, B., & Strauss, A. (1967). The discovery of grounded theory. Strategies for qualitative research. Chicago: Aldine.
9. Griffiths, F., Green, E., & Bendelow, G. (2006). Health professionals, their medical interventions and uncertainty: A study focusing on women at midlife. Social Science and Medicine, 62, 1078-1090.
10. Hoffmann, M., Hammar, M., Kjellgren, K.I., Lindh-Astrand, L., & Ahlner, J. (2006). Risk communication in consultations about hormone therapy in the menopause: Concordance in risk assessment and framing due to the context. Climacteric, 9, 347-354.
11. Hoffmann, M., Lindh-Astrand, L., Ahlner, J., Hammar, M., & Kjellgren, K.I. (2005). Hormone replacement therapy in the menopause. Structure and content of risk talk. Maturitas. 50, 8-18.
12. Kittell, L.A. (1998). Keeping up appearances: The basic social process of the menopausal transition. Qualitative Health Research, 8, 618-633.
13. Marmoreo, J., Brown, J.B., Batty, H.R., Cummings, S., & Powell, M. (1998). Hormone replacement therapy: Determinants of women's decisions. Patient Education and Counseling, 33, 289-298.
14. Murtagh, M.J., & Hepworth, J. (2003). Feminist ethics and menopause: Autonomy and decision-making in primary medical care. Social Science and Medicine, 56, 1643-1652.
15. National Institutes of Health. (2008). Women's Health Initiative. Questions and answers about the WHI Postmenopausal Hormone Therapy Trials. Retrieved January 18, 2008, from www.nhlbi.nih.gov/whi/ whi_faq.htm
16. Ness, J., & Aronow, W.S. (2006). Prevalence and causes of persistent use of hormone replacement therapy among postmenopausal women: A follow-up study. American Journal of Therapy, 13, 109-112.
17. Palmlund, I. (2006). Loyalties in clinical research on drugs: The case of hormone replacement therapy. Social Science and Medicine, 63, 540-551.
18. Schütze, F. (1983). Biographieforschung und narratives [Biographical research and narratives]. Neue Praxis, 13, 283-293.
19. Schwabe, U., & Paffrath, D. (2006). Arzneiverordnungsreport 2006. Berlin: Springer.
20. Stephens, C. (2002). Women's experience at the time of menopause: Accounting for biological, cultural and psychological embodiment. Journal of Health Psychology, 6, 651-663.
21. Stephens, C., & Breheny, M. (2008). Menopause and the virtuous woman: The importance of the moral order in accounting for medical decision making. Health, 17, 7. Retrieved January 18, 2008, from http://hea.sagepub.com/cgi/content/abstract/12/1/7
22. Writing Group for the Women's Health Initiative. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association, 288, 321-333.